Home › Atopic Dermatitis (Eczema) › Michigan › Ann Arbor
Atopic Dermatitis (Eczema) clinical trials in Ann Arbor, MI
4 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
RecruitingObservational study
- David Fivenson, MD, Dermatology, PLLC- Site Number : 8400017, Ann Arbor
Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
RecruitingHealthy volunteers welcome
- University of Michigan, Ann Arbor
Ethnic Differences in Mechanisms of Action of Dupilumab
RecruitingPhase 4
- University of Michigan, Ann Arbor
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
RecruitingPhase 2
- University of Michigan Health System - Ann Arbor /ID# 267275, Ann Arbor
Atopic Dermatitis (Eczema) trials in other cities
- New York City, NY13 studies
- Washington, DC11 studies
- Los Angeles, CA11 studies
- San Diego, CA10 studies
- San Antonio, TX10 studies
- Miami, FL9 studies
- Birmingham, AL9 studies
- Troy, MI8 studies
- Huntington Beach, CA8 studies
- Dallas, TX8 studies
- Sacramento, CA8 studies
- Indianapolis, IN7 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer26 studies
- Cancer (all types)25 studies
- Colorectal Cancer23 studies
- Lung Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.